Biotech grants in Switzerland

Funds late-stage clinical trials of vaccines, monoclonal antibodies and antivirals against a named list of lower respiratory tract infection pathogens in sub-Saharan Africa.

Funds clinical trials advancing new or improved antimalarial drug combinations toward registration and access in sub-Saharan Africa.

Funds 4 regional research networks in sub-Saharan Africa to run multi-country clinical trials and rapid outbreak-response research.

Funds Phase IIa-and-later clinical trials of new or shorter TB drug and chemoprophylaxis regimens for adults and children in sub-Saharan Africa.

Funds clinical trials of TB vaccine candidates and licensed vaccines targeting adolescents, adults and vulnerable groups in sub-Saharan Africa.

Funds clinical trials or large-scale implementation research on climate-sensitive water- and vector-borne disease control in sub-Saharan Africa and Europe.

Funds late-stage clinical trials on treating co-infections and co-morbidities in people living with HIV, not HIV itself, across sub-Saharan Africa.

Funds host institutions in sub-Saharan Africa to run Master's fellowships and short courses in epidemiology, biostatistics and infectious-disease modelling, worth up to EUR 90,000 per fellow.

Closed

Funds a coordination project that studies and harmonises how industrial composting plants across Europe handle compostable packaging.

Closed

Funds research consortia, including businesses and startups, that study microbiomes across plants, humans and environments to unlock new food-system applications.

Funds one project to standardise beta-cell manufacturing, immune-tolerance strategies and clinical criteria that speed up cell therapy for type 1 diabetes.

Closed

Funds one consortium to run a microbiome research one-stop-shop and coordination hub for EU policymakers and regulators.

Closed

Funds R&D that turns existing food-safety science — molecular methods, genomics, photonics — into deployable tools against food fraud and safety risks.

Closed

Funds development of lab-grown human tissue models, organ-on-chip systems and AI-driven simulations that can replace animal testing in drug and medical device development.

Closed

Funds companies and researchers scaling up precision-fermentation microorganisms that turn captured CO2 into food nutrients.

Closed

Funds AU-EU research consortia developing locally-produced therapeutic and supplementary foods for child malnutrition in Africa.

Closed

Funds industry-academia consortia that refine and scale up the manufacturing process for one class of cell or gene therapy, from quality control through to deployment.

Closed

Funds research into the prevention, diagnosis and treatment of long-term health conditions that persist after a viral, bacterial, parasitic or fungal infection has cleared.

Closed

Pays one consortium to run a public-education and communication campaign on biotech-derived alternative proteins such as precision-fermentation foods.

Closed

Funds bio-based and nature-based reconstruction solutions for areas damaged by conflicts such as the wars in Ukraine and Gaza.

Closed

Funds transnational access to research infrastructure services in one of three areas — industrial biotechnology, radionuclide facilities, or climate prediction.

Funds retrofitting an existing industrial or biorefinery plant to produce higher-value bio-based chemicals or materials than its old process line.

Funds scale-up of protein extraction or production processes from alternative sources like plants, fungi, microorganisms or fermentation, aimed at food use.

Closed

Pays 75% (up to €75K) for satellite-based sustainable-pharma services.